# Periprosthetic Hip Joint Infection Involving Fusobacterium nucleatum With Subsequent Isolation of Acinetobacter baumannii: A Case Report

**Authors:** Stamatios A Papadakis, Stavros Lykos, Dimitrios Pallis, Panagiotis Mantzanas, Nikolaos Paraskevopoulos, Spyros Kamariotis

PMC · DOI: 10.7759/cureus.101719 · 2026-01-17

## TL;DR

A rare case of hip infection caused by two bacteria, Fusobacterium nucleatum and Acinetobacter baumannii, required multiple surgeries and targeted treatment to resolve successfully.

## Contribution

This case report highlights the microbiological evolution and management challenges in periprosthetic joint infections involving rare bacterial species.

## Key findings

- Initial treatment with DAIR failed to resolve the infection caused by Fusobacterium nucleatum.
- Subsequent isolation of Acinetobacter baumannii required tailored antimicrobial therapy and multiple surgical interventions.
- Staged revision arthroplasty and prolonged treatment led to successful infection eradication and functional recovery.

## Abstract

Periprosthetic joint infection (PJI) is a serious complication following total hip arthroplasty and is most commonly caused by Gram-positive organisms. Infections involving anaerobic bacteria or multidrug-resistant Gram-negative pathogens are rare and particularly challenging to manage. We report a case of periprosthetic hip infection in a female patient in whom Fusobacterium nucleatum (F. nucleatum) was initially isolated, followed by Acinetobacter baumannii (A. baumannii) later in the treatment course. Initial management with debridement, antibiotics, and implant retention (DAIR) was unsuccessful, necessitating implant removal, placement, and subsequent removal of a cement spacer, as well as prolonged targeted antimicrobial therapy, including cefiderocol. Following staged revision arthroplasty, successful infection eradication was achieved with an excellent functional outcome. This report highlights the complexity of PJI management, the potential for microbiologic evolution under antimicrobial pressure, and the importance of tailored surgical and antimicrobial strategies.

## Linked entities

- **Chemicals:** cefiderocol (PubChem CID 77843966)
- **Diseases:** periprosthetic joint infection (MONDO:0800179)
- **Species:** Fusobacterium nucleatum (taxon 851), Acinetobacter baumannii (taxon 470)

## Full-text entities

- **Diseases:** PJI (MESH:D057068), Infections (MESH:D007239)
- **Chemicals:** cefiderocol (MESH:C000612166)
- **Species:** Homo sapiens (human, species) [taxon 9606], Acinetobacter baumannii (species) [taxon 470], Fusobacterium nucleatum (species) [taxon 851]

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12907771/full.md

---
Source: https://tomesphere.com/paper/PMC12907771